PUBLISHER: 360iResearch | PRODUCT CODE: 1397839
PUBLISHER: 360iResearch | PRODUCT CODE: 1397839
The Transdermal Patches Market is projected to reach USD 24.84 billion by 2030 from USD 7.46 billion in 2022, at a CAGR of 16.21% during the forecast period.
Global Transdermal Patches Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2022] | USD 7.46 billion |
Estimated Year [2023] | USD 8.57 billion |
Forecast Year [2030] | USD 24.84 billion |
CAGR (%) | 16.21% |
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Transdermal Patches Market.
Based on Product, market is studied across Matrix, Multi-layer Drug-in-Adhesive, Reservoir, and Single-layer Drug-in-Adhesive. The Single-layer Drug-in-Adhesive commanded largest market share of 29.81% in 2022, followed by Matrix.
Based on Type, market is studied across Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, and Oxybutynin Transdermal Patch. The Buprenorphine Transdermal Patch commanded largest market share of 38.27% in 2022, followed by Fentanyl Transdermal Patch.
Based on Technology, market is studied across Chemical Enhancers, Electric Current, Mechanical Arrays, and Thermal Ablation. The Mechanical Arrays commanded largest market share of 42.18% in 2022, followed by Chemical Enhancers.
Based on Application, market is studied across Hormonal Therapy, Overactive Bladder, Pain Relief, and Smoking Reduction & Cessation Aid. The Pain Relief commanded largest market share of 41.09% in 2022, followed by Smoking Reduction & Cessation Aid.
Based on Distribution Channel, market is studied across Offline and Online. The Offline commanded largest market share of 82.62% in 2022, followed by Online.
Based on End Users, market is studied across Clinics, Home Care Settings, and Hospitals. The Hospitals commanded largest market share of 62.58% in 2022, followed by Home Care Settings.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.52% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is an indispensable tool for assessing the Transdermal Patches Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
The Market Share Analysis offers invaluable insights into the vendor landscape Transdermal Patches Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdhexPharma SAS, ALVOGEN, Amneal Pharmaceuticals, Inc., Bayer AG, BioNxt Solutions Inc., Bliss GVS Pharma Ltd., Boehringer Ingelheim International GmbH, Corium, Inc., Corsair Pharma, Inc., DifGen Pharmaceuticals LLC, Endo International plc, Gedeon Richter Plc, GlaxoSmithKline Plc, Icure Pharmaceutical Inc., Johnson & Johnson Services, Inc., LAVIPHARM GROUP HOLDING S.A., Luye Pharma Group Ltd, Medherant Limited, Nitto Denko Corporation, Novartis AG, Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc., Nutriband Inc, Perrigo Company plc, ProSolus, Inc., Purdue Pharma L.P., Sparsha Pharma International Pvt Ltd, Tapemark by LTS Lohmann Therapie-Systeme AG, Teikoku Seiyaku Co., Ltd., Tesa SE by Beiersdorf AG, Teva Pharmaceutical Industries Ltd., UCB S.A., Viatris Inc., and Zydus Group.
1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast for the Transdermal Patches Market?
2. Which products, segments, applications, and areas hold the highest investment potential in the Transdermal Patches Market?
3. What is the competitive strategic window for identifying opportunities in the Transdermal Patches Market?
4. What are the latest technology trends and regulatory frameworks in the Transdermal Patches Market?
5. What is the market share of the leading vendors in the Transdermal Patches Market?
6. Which modes and strategic moves are suitable for entering the Transdermal Patches Market?